Home Featured Page 2

Featured

Latest

Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD Microdosing No Better than Placebo in ADHD

February 2025 Psychedelic Patent Update: Terran Secures New Overlapping IP; Porta Sophia Becomes USPTO Information Source

Beyond Guinea Pigs: Ensuring Access to Psychedelic Therapies for Europeans

Psychedelic Culture by Chacruna Institute

Bicycle Day 2025 @ Meow Wolf Denver

Forging a Path to Access: Congressmen Correa and Bergman on the...

Neil Markey – Beckley Retreats

Pα+ Psychedelic Bulletin #189: Psychedelic Philanthropists Weigh In on New Administration;...

Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States

January 2025 Psychedelic Paten Update: Lykos’ New Continuation Applications; Ambio Files...

Microdosing, Psychedelic Science, and the Future of Mental Health with Paul...

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at...

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

123...283 Page 2 of 283

Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Fayzan Rab – Emory University

Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD Microdosing No Better than Placebo in ADHD

February 2025 Psychedelic Patent Update: Terran Secures New Overlapping IP; Porta Sophia Becomes USPTO Information Source

Beyond Guinea Pigs: Ensuring Access to Psychedelic Therapies for Europeans

Psychedelic Culture by Chacruna Institute

Bicycle Day 2025 @ Meow Wolf Denver

Forging a Path to Access: Congressmen Correa and Bergman on the...

Neil Markey – Beckley Retreats

Pα+ Psychedelic Bulletin #189: Psychedelic Philanthropists Weigh In on New Administration;...

Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States

January 2025 Psychedelic Paten Update: Lykos’ New Continuation Applications; Ambio Files...

Microdosing, Psychedelic Science, and the Future of Mental Health with Paul...

A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at...

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

EDITOR PICKS

Fayzan Rab – Emory University

Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Pα+ Psychedelic Bulletin #192: Psychedelic Safety; Compass’ Lacklustre Long-Term Data; LSD...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY